Company profile: VintaBio
1.1 - Company Overview
Company description
- Provider of cell and gene therapy manufacturing services to pharmaceutical and biotechnology organizations to alleviate the viral vector bottleneck. Offerings include GMP manufacturing with integrated supply chain, process development and toxicology materials from cell line to drug product, research vector production, analytical assays for quality control and release, and CMC support for IND and pre-BLA.
Products and services
- CMC Support: Delivers regulatory-grade assistance for IND applications and pre-BLA submissions through thoroughly characterized manufacturing processes for cell and gene therapy manufacturing
- GMP Manufacture Services: Supplies GMP-ready integrated supply chain and documentation to enable consistency and comparability in viral vector production for pharmaceutical and biotechnology organizations
- Process Development & Toxicology Material Services: Offers turn-key viral vector manufacturing from cell line to drug product, architecting process robustness to yield high-quality vectors for development and toxicology materials
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to VintaBio
Orgenesis
HQ: United States
Website
- Description: Provider of point-of-care platforms, technologies, and networks to develop, produce, and distribute advanced cell and gene therapies, including a novel diabetes treatment that converts liver cells into functional insulin-producing cells. Offers POCare Platform, Therapies, Technologies, and a global POCare Network to lower costs and accelerate market access.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Orgenesis company profile →
Nordic Bioscience
HQ: Denmark
Website
- Description: Provider of ECM-focused biomarker technologies and services for precision drug development, including Protein Fingerprint technology to quantify extracellular matrix fragments in blood, laboratory biomarker analysis for clinical trials, the PRO-C3 biomarker for type III collagen formation, and the GRIPonMASH platform for early MASH detection and management with AI-based decision support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nordic Bioscience company profile →
Eurogentec
HQ: Belgium
Website
- Description: Provider of GMP biopharmaceutical manufacturing and life science solutions for research, diagnostic and pharmaceutical markets, including large-scale production of plasmid DNA, recombinant proteins, antibody fragments, mRNA, vaccines and conjugates; complex and NGS oligonucleotides; peptide-oligo conjugates; custom RNA/DNA aptamers; reagents and kits, in compliance with local and international standards.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eurogentec company profile →
Societal CDMO
HQ: United States
Website
- Description: Provider of contract development and manufacturing services focused on small molecule therapies, including drug product formulation development; clinical and commercial manufacturing of solid and liquid products (including controlled substances and high-potency molecules); analytical development and QC testing; clinical trial packaging and labeling; and regulatory consulting and FDA submission support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Societal CDMO company profile →
PHMR
HQ: United Kingdom
Website
- Description: Provider of strategic consulting services to biopharmaceutical, diagnostics, MedTech, and life science companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PHMR company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for VintaBio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to VintaBio
2.2 - Growth funds investing in similar companies to VintaBio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for VintaBio
4.2 - Public trading comparable groups for VintaBio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →